These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2262210)

  • 1. A new insight into adriamycin-induced cardiotoxicity.
    Fu LX; Waagstein F; Hjalmarson A
    Int J Cardiol; 1990 Oct; 29(1):15-20. PubMed ID: 2262210
    [No Abstract]   [Full Text] [Related]  

  • 2. The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy.
    Marques-Aleixo I; Santos-Alves E; Oliveira PJ; Moreira PI; Magalhães J; Ascensão A
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):189-199. PubMed ID: 29408395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.
    Carvalho FS; Burgeiro A; Garcia R; Moreno AJ; Carvalho RA; Oliveira PJ
    Med Res Rev; 2014 Jan; 34(1):106-35. PubMed ID: 23494977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the anti-cancer drug adriamycin on the energy metabolism of rat heart as measured by in vivo 31P-NMR and implications for adriamycin-induced cardiotoxicity.
    Nicolay K; Aue WP; Seelig J; van Echteld CJ; Ruigrok TJ; de Kruijff B
    Biochim Biophys Acta; 1987 Jun; 929(1):5-13. PubMed ID: 3593774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.
    Pereira GC; Silva AM; Diogo CV; Carvalho FS; Monteiro P; Oliveira PJ
    Curr Pharm Des; 2011; 17(20):2113-29. PubMed ID: 21718248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.
    Wallace KB; Sardão VA; Oliveira PJ
    Circ Res; 2020 Mar; 126(7):926-941. PubMed ID: 32213135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice.
    Pillai VB; Kanwal A; Fang YH; Sharp WW; Samant S; Arbiser J; Gupta MP
    Oncotarget; 2017 May; 8(21):34082-34098. PubMed ID: 28423723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
    Lebrecht D; Geist A; Ketelsen UP; Haberstroh J; Setzer B; Walker UA
    Br J Pharmacol; 2007 Jul; 151(6):771-8. PubMed ID: 17519947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
    Carvalho RA; Sousa RP; Cadete VJ; Lopaschuk GD; Palmeira CM; Bjork JA; Wallace KB
    Toxicology; 2010 Apr; 270(2-3):92-8. PubMed ID: 20132857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
    Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
    Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of doxorubicin-induced cardiomyopathy - An update.
    Renu K; V G A; P B TP; Arunachalam S
    Eur J Pharmacol; 2018 Jan; 818():241-253. PubMed ID: 29074412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raising the Dead: Mitochondrial Cardiolipin as a Key Target for Post-Cardiac Arrest Resuscitation, Ischaemia-Reperfusion Injury and Cardiomyopathy.
    Pepe S
    Heart Lung Circ; 2019 Mar; 28(3):360-363. PubMed ID: 30712658
    [No Abstract]   [Full Text] [Related]  

  • 13. Electron spin resonance studies on the mechanism of adriamycin-induced heart mitochondrial damages.
    Ogura R; Sugiyama M; Haramaki N; Hidaka T
    Cancer Res; 1991 Jul; 51(13):3555-8. PubMed ID: 1647271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction.
    Dolinsky VW
    Biol Chem; 2017 Aug; 398(9):955-974. PubMed ID: 28253192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes.
    Zhang Y; Chen L; Li F; Wang H; Yao Y; Shu J; Ying MZ
    Pharm Biol; 2016; 54(2):237-42. PubMed ID: 25858002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagic dysregulation in doxorubicin cardiomyopathy.
    Bartlett JJ; Trivedi PC; Pulinilkunnil T
    J Mol Cell Cardiol; 2017 Mar; 104():1-8. PubMed ID: 28108310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury.
    Chaiswing L; Cole MP; St Clair DK; Ittarat W; Szweda LI; Oberley TD
    Toxicol Pathol; 2004; 32(5):536-47. PubMed ID: 15605432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-induced cardiac mitochondrionopathy.
    Wallace KB
    Pharmacol Toxicol; 2003 Sep; 93(3):105-15. PubMed ID: 12969434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiotoxicity of adriamycin].
    Mordeglia F; Mirassou C
    Medicina (B Aires); 1979; 39(3):423-5. PubMed ID: 514062
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin.
    Peitsch MC; Tschopp J; Kress A; Isliker H
    Biochem J; 1988 Jan; 249(2):495-500. PubMed ID: 3277626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.